arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

ESTABLISHMENT LABS HOLDINGS INC.

ESTA
$64.33 ▼ -2.58 (-3.85%) at close
Healthcare ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·USOrthopedic, Prosthetic & Surgical Appliances & Supplies
10 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

ESTABLISHMENT LABS HOLDINGS INC. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.9B
Dividend Yield —
Revenue Growth 27.1% ↗
Op. Margin -18.5% ↗
ROIC -12.7% ↗
FCF / Share $-1.92 ↗
Trailing P/E —
Price / Book 80.1x
FCF Yield —
Debt / Equity 10.51
info Valuation on last close. End-of-day price, Nov 5, 2026.

10-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$211.08M
↑ +27.1% —
Net Income Profit after all expenses
$-51.06M
↑ +39.6% —
Operating Margin Operating profit as % of sales
-18.5%
↑ +38.6% 11th
FCF / Share Free cash flow per share
$-1.92
↑ +16.2% —
Long-Term Debt Long-term obligations
$247.52M
— —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑
9
Returns ↓
1
Financial Health ↑
22
Cash Quality ↑
70

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 10 years · 39 quarters